Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics Properties, and Preliminary Efficacy of 9MW3811 in Patients With Pathological Scar (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics Properties, and Preliminary Efficacy of 9MW3811 in Patients With Pathological Scar'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129915

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332428

Published by HT Digital Content Services with permission from Health Daily Digest....